Our research involves the application of nutrition and nutrigenetics to the nutraceutical prevention and post-onset management of type 2 diabetes in humans, with a view to the reduction of polypharmacy.
Identification and quantification of proteins and other biomolecules using advanced mass spectrometry methods and discovery of novel drug candidates through integrated bioanalytical services.